[
  {
    "id": "TCGA-BH-A18U-01Z-00-DX1.63940315-59BC-462B-87A8-2BBB33C9503E-1",
    "image": "TCGA-BRCA/TCGA-BH-A18U-01Z-00-DX1.63940315-59BC-462B-87A8-2BBB33C9503E.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results showing positive estrogen receptor (ER) expression, mixed progesterone receptor (PR) positivity, and strongly positive Her2/neu status (3+), what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-TQ-A7RO-01Z-00-DX1.18B7FCA6-3AD0-43A1-B117-A9C8017DD783-1",
    "image": "TCGA-LGG/TCGA-TQ-A7RO-01Z-00-DX1.18B7FCA6-3AD0-43A1-B117-A9C8017DD783.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing positive expression of GFAP, Bcl-2, and P53, and negative expression of Galectin-3, what is the molecular subtype in this glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-codel."
      }
    ]
  },
  {
    "id": "TCGA-DH-5143-01Z-00-DX1.DD05DCF6-FF16-47A3-B3EF-FCB89F6C8566-1",
    "image": "TCGA-LGG/TCGA-DH-5143-01Z-00-DX1.DD05DCF6-FF16-47A3-B3EF-FCB89F6C8566.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing a Ki-67 labeling index of 5-10% in areas of increased cellularity, P53 immunoreactivity in slightly greater than 50% of tumor cells, and variable GFAP reactivity throughout the tumor, what is the molecular subtype in this low-grade glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1LL-01Z-00-DX1.D1AA1613-902C-4579-9612-48A76042B0AE-1",
    "image": "TCGA-BRCA/TCGA-E2-A1LL-01Z-00-DX1.D1AA1613-902C-4579-9612-48A76042B0AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results showing negative expression for estrogen receptor (ER), progesterone receptor (PR), and Her2, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L8-01Z-00-DX1.842BF73D-2D64-4ABA-880D-DBE8F4C2AA19-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L8-01Z-00-DX1.842BF73D-2D64-4ABA-880D-DBE8F4C2AA19.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results with positive ER and PR, negative Her2 by FISH, and ER Allred Score of 8, along with a PR Allred Score of 6, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-BA-A6DE-01Z-00-DX1.3279D372-4A92-4CFA-9E52-19197934378D-1",
    "image": "TCGA-HNSC/TCGA-BA-A6DE-01Z-00-DX1.3279D372-4A92-4CFA-9E52-19197934378D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing P16 negativity and HR, HPV ISH status negativity, what is the molecular subtype in this head and neck squamous cell carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is HNSC_HPV-."
      }
    ]
  },
  {
    "id": "TCGA-DU-7019-01Z-00-DX1.94F228DF-0184-4D7F-9899-CCFEE24959C4-1",
    "image": "TCGA-LGG/TCGA-DU-7019-01Z-00-DX1.94F228DF-0184-4D7F-9899-CCFEE24959C4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing GFAP demonstrating frequent reactive-type astrocytes, strong overexpression of p53 in the majority of neoplastic cells, a proliferation index up to about 108, and focal subtle microvascular hyperplasia demonstrated by CD31 and CD34, what is the molecular subtype in this glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-DU-A7T8-01Z-00-DX1.2D5A2041-46F5-4571-A933-2629E7617B31-1",
    "image": "TCGA-LGG/TCGA-DU-A7T8-01Z-00-DX1.2D5A2041-46F5-4571-A933-2629E7617B31.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing sparse gliofibrilogenesis by neoplastic cells with GFAP, rich vascularity within the neoplasm with CD34, about 5% of cells over-expressing the p53 antigen, and a proliferation index of 3% in more cellular areas with MIB-1, what is the molecular subtype in this glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0C1-01Z-00-DX1.21FE357E-B182-4397-BFEF-7E96E994236A-1",
    "image": "TCGA-BRCA/TCGA-BH-A0C1-01Z-00-DX1.21FE357E-B182-4397-BFEF-7E96E994236A.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results indicating positive expression for ER and PR, along with a negative IHC score of 0 for HER-2/neu, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-HT-A61C-01Z-00-DX1.034BF077-8710-4F6A-B346-67740B77A277-1",
    "image": "TCGA-LGG/TCGA-HT-A61C-01Z-00-DX1.034BF077-8710-4F6A-B346-67740B77A277.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing a 34.7% MIB-1 labeling index, minority positive p53, and negative IDH1, what is the molecular subtype in this left temporal anaplastic oligodendroglioma, grade III?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHwt."
      }
    ]
  },
  {
    "id": "TCGA-C8-A12K-01Z-00-DX1.D71C7974-65F7-4EF0-8FFB-9F27CEC85242-1",
    "image": "TCGA-BRCA/TCGA-C8-A12K-01Z-00-DX1.D71C7974-65F7-4EF0-8FFB-9F27CEC85242.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing negative ER, PR, and Her-2/neu status, along with negative B-Cell and T-Cell markers, what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-D8-A1JA-01Z-00-DX1.BD43F94A-D5A8-490E-AED4-5F3AB24080FA-1",
    "image": "TCGA-BRCA/TCGA-D8-A1JA-01Z-00-DX1.BD43F94A-D5A8-490E-AED4-5F3AB24080FA.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the immunohistochemical results with less than 10% positivity for estrogen receptors, no detected progesterone receptors, and a positive Her2 protein reaction with a score of 3+, what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Her2."
      }
    ]
  },
  {
    "id": "TCGA-DU-6406-01Z-00-DX1.ad212563-154d-4090-b86c-40d91b4d9e48-1",
    "image": "TCGA-LGG/TCGA-DU-6406-01Z-00-DX1.ad212563-154d-4090-b86c-40d91b4d9e48.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing GFAP highlighting the fine gliofibrillary background and an MIB-1 proliferation index of 22%, what is the molecular subtype in this low-grade glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHwt."
      }
    ]
  },
  {
    "id": "TCGA-HT-A5RB-01Z-00-DX1.6928817C-E954-4245-85D4-90D4501E2424-1",
    "image": "TCGA-LGG/TCGA-HT-A5RB-01Z-00-DX1.6928817C-E954-4245-85D4-90D4501E2424.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing diffusely immunoreactive p53 and MIB-1 with a labeling index of 2.8%, what is the molecular subtype in this well-differentiated astrocytoma (right frontal brain tumor, WHO Grade II)?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8-1",
    "image": "TCGA-BRCA/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results of 0% nuclear staining for both estrogen and progesterone receptors, and the absence of metastatic disease in cytokeratins, what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-AR-A24H-01Z-00-DX1.5CFC7E16-3F38-4531-968C-A4E4C9D00659-1",
    "image": "TCGA-BRCA/TCGA-AR-A24H-01Z-00-DX1.5CFC7E16-3F38-4531-968C-A4E4C9D00659.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive expression for both estrogen receptor (ER) and progesterone receptor (PR), what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-BA-A8YP-01Z-00-DX1.03B95E63-2639-49F6-B8DD-AC2C2FA872B1-1",
    "image": "TCGA-HNSC/TCGA-BA-A8YP-01Z-00-DX1.03B95E63-2639-49F6-B8DD-AC2C2FA872B1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing negative P16 immunohistochemical staining and negative High Risk HPV ISH, what is the molecular subtype in this head and neck squamous cell carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is HNSC_HPV-."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1OX-01Z-00-DX1.9B19CBEE-E592-4A4D-839F-CECDCA20F4B1-1",
    "image": "TCGA-BRCA/TCGA-EW-A1OX-01Z-00-DX1.9B19CBEE-E592-4A4D-839F-CECDCA20F4B1.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive ER and PR status, negative Her2 expression, and keratin negative for carcinoma in sentinel nodes, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-AO-A0J7-01Z-00-DX1.DBA7BA24-CEEF-4636-87BB-D12D8DF016A3-1",
    "image": "TCGA-BRCA/TCGA-AO-A0J7-01Z-00-DX1.DBA7BA24-CEEF-4636-87BB-D12D8DF016A3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results with positive estrogen receptor (90% strong nuclear staining), negative progesterone receptor, negative Her2, and positive E-cadherin, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-EW-A1J2-01Z-00-DX1.F1D8E593-2DF4-44C3-873D-FD3C910011E4-1",
    "image": "TCGA-BRCA/TCGA-EW-A1J2-01Z-00-DX1.F1D8E593-2DF4-44C3-873D-FD3C910011E4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive ER and PR status, negative Her-2 and E-cadherin, and immunoreactive tumor cells present for predictive markers, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-B6-A0RV-01Z-00-DX1.C46C2937-868D-47B7-B9B9-E51F5433BE97-1",
    "image": "TCGA-BRCA/TCGA-B6-A0RV-01Z-00-DX1.C46C2937-868D-47B7-B9B9-E51F5433BE97.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith immunohistochemical results showing positive estrogen receptor (ER) and progesterone receptor (PR) with high fmol values, what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-EO-A1Y5-01Z-00-DX1.E32687DB-FBDD-40E3-BBD2-9BD3BE53C769-1",
    "image": "TCGA-UCEC/TCGA-EO-A1Y5-01Z-00-DX1.E32687DB-FBDD-40E3-BBD2-9BD3BE53C769.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing diffuse and strong positivity for P53 and p16, focal positivity for ER, negativity for WT-1 and PR, and intact MSH-6, PMS-2, MLH-1, and MLH-2, what is the molecular subtype in this endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is CN_HIGH."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0T3-01Z-00-DX1.5E96BC87-F4FB-4ABA-8D81-FAB7F4A80661-1",
    "image": "TCGA-BRCA/TCGA-A2-A0T3-01Z-00-DX1.5E96BC87-F4FB-4ABA-8D81-FAB7F4A80661.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive cytokeratin staining in the first sentinel lymph node and negative cytokeratin staining in the second axillary lymph node biopsy, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-E2-A150-01Z-00-DX1.55643D23-83E6-4058-8EA5-18AAA8547839-1",
    "image": "TCGA-BRCA/TCGA-E2-A150-01Z-00-DX1.55643D23-83E6-4058-8EA5-18AAA8547839.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing negative ER and PR with an Allred Score of 0, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-A1-A0SJ-01Z-00-DX1.C196FA66-C376-4016-86BC-3D8E745B3A51-1",
    "image": "TCGA-BRCA/TCGA-A1-A0SJ-01Z-00-DX1.C196FA66-C376-4016-86BC-3D8E745B3A51.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the provided immunohistochemical results, which show positive expression for estrogen receptors with strong nuclear staining in more than 70% of breast tumor cells and positive progesterone receptors with at least weak nuclear staining in over 10% of breast tumor cells, what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0EB-01Z-00-DX1.70D7BBA0-214D-4D1A-933C-7CFCDA5416A3-1",
    "image": "TCGA-BRCA/TCGA-BH-A0EB-01Z-00-DX1.70D7BBA0-214D-4D1A-933C-7CFCDA5416A3.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results showing positive estrogen receptors, positive progesterone receptors, and HER-2 negative status (FISH not amplified), what is the molecular subtype of this breast tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0E2-01Z-00-DX1.5F6FA19C-D59F-45BE-80CE-F738CAB1EF0B-1",
    "image": "TCGA-BRCA/TCGA-BH-A0E2-01Z-00-DX1.5F6FA19C-D59F-45BE-80CE-F738CAB1EF0B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive estrogen and progesterone receptors, with negative Her2 status, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-AJ-A3BH-01Z-00-DX1.0331F525-1598-40D2-95C9-D480F7F57AE4-1",
    "image": "TCGA-UCEC/TCGA-AJ-A3BH-01Z-00-DX1.0331F525-1598-40D2-95C9-D480F7F57AE4.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing Estrogen receptor: Positive, Progesterone receptor: Negative, Cytokeratin AE1/AE3: Positive, WT1: Negative, p16: Patchy positivity, and p53: Negative, what is the molecular subtype in this endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is UCEC_MSI."
      }
    ]
  },
  {
    "id": "TCGA-DU-A7TA-01Z-00-DX1.C0013D54-C292-4060-99F6-A6AB4E54FAA5-1",
    "image": "TCGA-LGG/TCGA-DU-A7TA-01Z-00-DX1.C0013D54-C292-4060-99F6-A6AB4E54FAA5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC result showing an MIB-1 labeling index of 2%, what is the molecular subtype in this low-grade glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-AJ-A5DW-01Z-00-DX1.43384999-B08F-4D79-AD31-7194C28B04D5-1",
    "image": "TCGA-UCEC/TCGA-AJ-A5DW-01Z-00-DX1.43384999-B08F-4D79-AD31-7194C28B04D5.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing intact MLH1, PMS2, MSH2, and MSH6, what is the molecular subtype in this uterine endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is UCEC_POLE."
      }
    ]
  },
  {
    "id": "TCGA-E2-A1L7-01Z-00-DX1.BE796CD2-2E81-44E8-8CA2-85B4D2A31B64-1",
    "image": "TCGA-BRCA/TCGA-E2-A1L7-01Z-00-DX1.BE796CD2-2E81-44E8-8CA2-85B4D2A31B64.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing negative estrogen receptor (ER), negative progesterone receptor (PR), and HER2 negative by IHC, what is the molecular subtype of this tumor?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LumB."
      }
    ]
  },
  {
    "id": "TCGA-H7-A76A-01Z-00-DX1.E4D824E3-2076-4E46-83F8-9BF5283FCDEE-1",
    "image": "TCGA-HNSC/TCGA-H7-A76A-01Z-00-DX1.E4D824E3-2076-4E46-83F8-9BF5283FCDEE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing p16 positivity and HPV high-risk (16/18) positivity, what is the molecular subtype in this head and neck squamous cell carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is HNSC_HPV+."
      }
    ]
  },
  {
    "id": "TCGA-EY-A2OM-01Z-00-DX1.A704D5CF-011B-4A17-AA5D-1634556CC719-1",
    "image": "TCGA-UCEC/TCGA-EY-A2OM-01Z-00-DX1.A704D5CF-011B-4A17-AA5D-1634556CC719.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing positive Estrogen Receptor (2+, 50%), negative Progesterone Receptor, weak P53 staining, patchy P16 staining, and negative Synaptophysin and Chromogranin, what is the molecular subtype in this endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is UCEC_MSI."
      }
    ]
  },
  {
    "id": "TCGA-BH-A1FG-01Z-00-DX1.DA665FB6-9DD9-4B18-A925-2EFD9BC4C43B-1",
    "image": "TCGA-BRCA/TCGA-BH-A1FG-01Z-00-DX1.DA665FB6-9DD9-4B18-A925-2EFD9BC4C43B.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical results showing positive estrogen and progesterone receptors with negative HER-2/neu status, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-LL-A5YP-01Z-00-DX1.ADA978DF-6625-4C4D-AE0C-F589B2BA4897-1",
    "image": "TCGA-BRCA/TCGA-LL-A5YP-01Z-00-DX1.ADA978DF-6625-4C4D-AE0C-F589B2BA4897.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nConsidering the immunohistochemical results showing positive ER (26% with weak intensity), negative PR, equivocal Her2 (2+) with FISH not amplified but in situ hybridization amplified, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16-1",
    "image": "TCGA-BRCA/TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nGiven the immunohistochemical analysis indicating positive estrogen receptor status, negative progesterone receptor status, and positive Her2 expression, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal B."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB-1",
    "image": "TCGA-BRCA/TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive estrogen and progesterone receptors and Her2/neu score of 2+, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-A2-A0ES-01Z-00-DX1.5652EE30-48C1-4EC1-AD77-8C72DFCB9A97-1",
    "image": "TCGA-BRCA/TCGA-A2-A0ES-01Z-00-DX1.5652EE30-48C1-4EC1-AD77-8C72DFCB9A97.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive estrogen receptor expression, negative progesterone receptor status, and equivocal Her2 status (weakly positive IHC 2+ but negative FISH), what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD-1",
    "image": "TCGA-BRCA/TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results with positive estrogen receptor (ER) and progesterone receptor (PR) expression, Her2 not amplified, and negative AE1/AE3, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  },
  {
    "id": "TCGA-JX-A3Q8-01Z-00-DX1.4995F70C-BDBE-4435-B57B-C6ACC27B0E91-1",
    "image": "TCGA-CESC/TCGA-JX-A3Q8-01Z-00-DX1.4995F70C-BDBE-4435-B57B-C6ACC27B0E91.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing the endocervical adenocarcinoma tumor cells are diffusely positive for p16 by immunohistochemical stain, what is the molecular subtype in this endocervical adenocarcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is CESC_AdenoCarcinoma."
      }
    ]
  },
  {
    "id": "TCGA-BH-A42U-01Z-00-DX1.130D060A-3DD8-407E-B8B0-EBBF743491AE-1",
    "image": "TCGA-BRCA/TCGA-BH-A42U-01Z-00-DX1.130D060A-3DD8-407E-B8B0-EBBF743491AE.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nWith the immunohistochemical result indicating a negative expression for cadherin, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Normal."
      }
    ]
  },
  {
    "id": "TCGA-TM-A7C4-01Z-00-DX1.082C7A0D-CCAA-4D40-B7B5-1CDD1812DF57-1",
    "image": "TCGA-LGG/TCGA-TM-A7C4-01Z-00-DX1.082C7A0D-CCAA-4D40-B7B5-1CDD1812DF57.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing Ki-67 immunoreactivity in astrocytic cells of less than 4%, what is the molecular subtype in this low-grade glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-DH-A7UR-01Z-00-DX1.CD0C3921-255F-4415-BE61-240068DD1C9D-1",
    "image": "TCGA-LGG/TCGA-DH-A7UR-01Z-00-DX1.CD0C3921-255F-4415-BE61-240068DD1C9D.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing a Ki-67 labeling index of 15-20% and GFAP immunoreactivity in a few scattered cells but negative in the majority of the tumor, what is the molecular subtype in this glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-codel."
      }
    ]
  },
  {
    "id": "TCGA-HT-7884-01Z-00-DX1.36807827-67BE-4B0A-B750-F0690B3CB091-1",
    "image": "TCGA-LGG/TCGA-HT-7884-01Z-00-DX1.36807827-67BE-4B0A-B750-F0690B3CB091.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing numerous cells are immunoreactive for p53 and a MIB-1 labeling index of 2.5%, what is the molecular subtype in this glioma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is LGG_IDHmut-non-codel."
      }
    ]
  },
  {
    "id": "TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55-1",
    "image": "TCGA-BRCA/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on immunohistochemical results showing negative estrogen and progesterone receptors, and a Her2/NEU score of 1+, what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Basal."
      }
    ]
  },
  {
    "id": "TCGA-AX-A06F-01Z-00-DX1.0DA1ED86-DF47-4357-B301-BFE32DB9E241-1",
    "image": "TCGA-UCEC/TCGA-AX-A06F-01Z-00-DX1.0DA1ED86-DF47-4357-B301-BFE32DB9E241.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing strong Cytokeratin 7 reactivity, focal strong dot cytoplasmic reactivity of Cytokeratin 20 in the ileum, focal reactivity of Chromogranin in the endometrium and ileum, no reactivity of Synaptophysin, and weak reactivity of CD56 in the ileum, what is the molecular subtype in this endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is UCEC_POLE."
      }
    ]
  },
  {
    "id": "TCGA-AX-A06F-01Z-00-DX2.0046C5EE-7C44-4CE8-977A-A8BD3CC331B0-1",
    "image": "TCGA-UCEC/TCGA-AX-A06F-01Z-00-DX2.0046C5EE-7C44-4CE8-977A-A8BD3CC331B0.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the IHC results showing strong Cytokeratin 7 reactivity, focal strong dot cytoplasmic reactivity of Cytokeratin 20 in the ileum, focal reactivity of Chromogranin in the endometrium and ileum, no reactivity of Synaptophysin, and weak reactivity of CD56 in the ileum, what is the molecular subtype in this endometrial carcinoma?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is UCEC_POLE."
      }
    ]
  },
  {
    "id": "TCGA-S3-AA14-01Z-00-DX1.000A865F-19E6-4018-9352-BFA54EF0CE31-1",
    "image": "TCGA-BRCA/TCGA-S3-AA14-01Z-00-DX1.000A865F-19E6-4018-9352-BFA54EF0CE31.pt",
    "conversations": [
      {
        "from": "human",
        "value": "<image>\nBased on the immunohistochemical results showing positive Her2/NEU expression (Score 3+), positive estrogen receptor (75%), and positive progesterone receptor (75%), what is the molecular subtype of this breast cancer?"
      },
      {
        "from": "gpt",
        "value": "The molecular subtype is Luminal A."
      }
    ]
  }
]